Susana Roselló-rekin lankidetzan egindako argitalpenak (6)

2020

  1. Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

    ESMO Open, Vol. 5, Núm. 5

  2. Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 63-72

2019

  1. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

    Modern Pathology, Vol. 32, Núm. 2, pp. 306-313

  2. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, Núm. 11, pp. 1804-1812

2018

  1. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2

2015

  1. Selective approach for upper rectal cancer treatment: Total mesorectal excision and preoperative chemoradiation are seldom necessary

    Diseases of the Colon and Rectum, Vol. 58, Núm. 6, pp. 556-565